PL436869A1 - Kompozycja oraz sposób nieterapeutycznego złuszczania naskórka - Google Patents
Kompozycja oraz sposób nieterapeutycznego złuszczania naskórkaInfo
- Publication number
- PL436869A1 PL436869A1 PL436869A PL43686921A PL436869A1 PL 436869 A1 PL436869 A1 PL 436869A1 PL 436869 A PL436869 A PL 436869A PL 43686921 A PL43686921 A PL 43686921A PL 436869 A1 PL436869 A1 PL 436869A1
- Authority
- PL
- Poland
- Prior art keywords
- exfoliation
- epidermis
- therapeutic
- composition
- retinol
- Prior art date
Links
- 210000002615 epidermis Anatomy 0.000 title abstract 2
- 238000004299 exfoliation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 2
- 229960003471 retinol Drugs 0.000 abstract 2
- 235000020944 retinol Nutrition 0.000 abstract 2
- 239000011607 retinol Substances 0.000 abstract 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 abstract 1
- 241000207746 Nicotiana benthamiana Species 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Przedmiotem wynalazku jest kompozycja na bazie wodno-alkoholowej, zawierająca retinol, która zawiera retinol w stężeniu 3 - 7% wag., oraz składnik o nazwie INCI Nicotiana Benthamiana Hexapeptide-40 sh-Polypeptide-76. Przedmiotem wynalazku jest także sposób nieterapeutycznego złuszczania zewnętrznych warstw naskórka.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL436869A PL436869A1 (pl) | 2021-02-04 | 2021-02-04 | Kompozycja oraz sposób nieterapeutycznego złuszczania naskórka |
| PCT/IB2022/050974 WO2022167984A1 (en) | 2021-02-04 | 2022-02-04 | Composition and method of non-therapeutic exfoliation of the epidermis |
| EP22712443.5A EP4288025B1 (en) | 2021-02-04 | 2022-02-04 | Composition and method of non-therapeutic exfoliation of the epidermis |
| PL22712443.5T PL4288025T3 (pl) | 2021-02-04 | 2022-02-04 | Kompozycja oraz sposób nieterapeutycznego złuszczania naskórka |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL436869A PL436869A1 (pl) | 2021-02-04 | 2021-02-04 | Kompozycja oraz sposób nieterapeutycznego złuszczania naskórka |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL436869A1 true PL436869A1 (pl) | 2022-08-08 |
Family
ID=80933206
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL436869A PL436869A1 (pl) | 2021-02-04 | 2021-02-04 | Kompozycja oraz sposób nieterapeutycznego złuszczania naskórka |
| PL22712443.5T PL4288025T3 (pl) | 2021-02-04 | 2022-02-04 | Kompozycja oraz sposób nieterapeutycznego złuszczania naskórka |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22712443.5T PL4288025T3 (pl) | 2021-02-04 | 2022-02-04 | Kompozycja oraz sposób nieterapeutycznego złuszczania naskórka |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4288025B1 (pl) |
| PL (2) | PL436869A1 (pl) |
| WO (1) | WO2022167984A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115969730A (zh) * | 2022-12-22 | 2023-04-18 | 诺德溯源(广州)生物科技有限公司 | 一种紧致提拉肌肤的组合物及其制备方法和应用 |
| EP4744644A1 (en) * | 2024-11-15 | 2026-05-20 | Prima-Derm, S.L. | COSMETIC PREPARATION TO REJUVENATE THE SKIN |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100377397B1 (ko) * | 1999-12-23 | 2003-03-26 | 주식회사 대웅 | 레티놀 및 표피성장인자를 함유하는 피부보호 화장료 조성물 |
| WO2015197877A1 (es) * | 2014-06-24 | 2015-12-30 | Dermopartners, S.L. | Producto cosmetico con factores de crecimiento liposomados |
| EP3490525A4 (en) * | 2016-07-28 | 2020-04-08 | Jonas Wang | SKIN CARE PRODUCTS AND USES THEREOF |
| US20210275495A1 (en) * | 2017-06-23 | 2021-09-09 | Vivier Canada Inc. | Putrescine topical formulations |
-
2021
- 2021-02-04 PL PL436869A patent/PL436869A1/pl unknown
-
2022
- 2022-02-04 EP EP22712443.5A patent/EP4288025B1/en active Active
- 2022-02-04 PL PL22712443.5T patent/PL4288025T3/pl unknown
- 2022-02-04 WO PCT/IB2022/050974 patent/WO2022167984A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4288025B1 (en) | 2025-04-09 |
| PL4288025T3 (pl) | 2025-07-14 |
| WO2022167984A1 (en) | 2022-08-11 |
| EP4288025A1 (en) | 2023-12-13 |
| EP4288025C0 (en) | 2025-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Richards | Review finds that severe periodontitis affects 11% of the world population. | |
| EA200801632A1 (ru) | Экстракт, обогащенный проантоцианидинами, и способ его получения | |
| WO2011163062A3 (en) | Personal assistant for task utilization | |
| BRPI0921482A8 (pt) | Uso de uma construção de anticorpo de cadeia simples biespecífica cd19xcd3 no tratamento de leucemia linfoblástica aguda | |
| BR112014013786A8 (pt) | método para ventilação de um indivíduo, método para rapidamente ventilar um indivíduo que apresenta desconforto respiratório, e, dispositivo para ventilação de um indivíduo através de uma ou mais passagens do corpo | |
| MX381380B (es) | Factores de transcripción que regulan la biosíntesis de nicotina en el tabaco. | |
| MX2016007838A (es) | Composiciones para el cuidado oral que contienen carbonato de calcio y silice. | |
| MY150829A (en) | Oral compositions containing extracts of myristica fragrans and related methods | |
| ZA202310173B (en) | Oral care flavour for improving happiness state and method of assessing | |
| ZA202302276B (en) | Methods and compositions for treating coronavirus infections | |
| MX2020004422A (es) | Formulacion vaporizable saborizada. | |
| WO2020165464A3 (en) | Improvements in or relating to organic compounds | |
| BR112013003883A2 (pt) | composições que compreendem paulownina e/ou extratos de paulônia e usos das mesmas | |
| BR112012020740A2 (pt) | materiais de sílica para reduzir mau hálito | |
| BR112013033169A8 (pt) | composição que compreende um primeiro extrato de cebola (a) e lipossomas, método para a preparação de uma composição. | |
| WO2021020994A3 (ru) | Комплекс для профилактики оксидативного стресса полости рта | |
| MX2024001354A (es) | Conservantes para composiciones cosmeticas y farmaceuticas. | |
| Stratilatis | On the distinction between statements of fact and value judgments: A comment on Petrenco v. Moldova | |
| PE20210319A1 (es) | Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas | |
| BR112012016465A2 (pt) | mudança de cor de formulações para cuidado oral contendo chalcona. | |
| PL436015A1 (pl) | Naturalny preparat antymikrobiologiczny na bazie etanolowego ekstraktu z liści maliny, sposób jego otrzymywania i zastosowanie | |
| Khajanchi et al. | Indians fit the Asian trauma model | |
| MX2024002867A (es) | Composiciones que contienen cariofileno. | |
| MX2023009775A (es) | Composiciones biocidas y usos de las mismas. | |
| Ismail et al. | A Review on Prevention, Treatment and Potential Mechanism of Honey Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |